Patents by Inventor Terrence PARK

Terrence PARK has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FUSIONS WITH CD8 ANTIGEN BINDING MOLECULES FOR MODULATING IMMUNE CELL FUNCTION
    Publication number: 20240417470
    Abstract: Provided herein are anti-CD8 antigen binding molecules and fusion polypeptides comprising the CD8 antigen binding molecules for selectively modulating the function of CD8+ T cells over other immune cells. In addition, the present disclosure also provides polynucleotides encoding the disclosed antigen binding molecules and fusion polypeptides, and vectors and host cells comprising such polynucleotides. The present disclosure further provides methods for producing the antigen binding molecules and fusion polypeptides, pharmaceutical compositions comprising the same, and uses thereof.
    Type: Application
    Filed: May 13, 2024
    Publication date: December 19, 2024
    Inventors: Yik Andy YEUNG, Ivana DJURETIC, Paul BESSETTE, Wei CHEN, Sherman Michael CHIN, Kelly Dare MOYNIHAN, Henry C. NGUYEN, Irene NI, Danielle C. PAPPAS, Terrence PARK
  • Fusions with CD8 antigen binding molecules for modulating immune cell function
    Patent number: 12024559
    Abstract: Provided herein are anti-CD8 antigen binding molecules and fusion polypeptides comprising the CD8 antigen binding molecules for selectively modulating the function of CD8+ T cells over other immune cells. In addition, the present disclosure also provides polynucleotides encoding the disclosed antigen binding molecules and fusion polypeptides, and vectors and host cells comprising such polynucleotides. The present disclosure further provides methods for producing the antigen binding molecules and fusion polypeptides, pharmaceutical compositions comprising the same, and uses thereof.
    Type: Grant
    Filed: October 22, 2021
    Date of Patent: July 2, 2024
    Assignee: Asher Biotherapeutics, Inc.
    Inventors: Yik Andy Yeung, Ivana Djuretic, Paul Bessette, Wei Chen, Sherman Michael Chin, Kelly Dare Moynihan, Henry C. Nguyen, Irene Ni, Danielle C. Pappas, Terrence Park
  • FUSIONS WITH CD8 ANTIGEN BINDING MOLECULES FOR MODULATING IMMUNE CELL FUNCTION
    Publication number: 20220162314
    Abstract: Provided herein are anti-CD8 antigen binding molecules and fusion polypeptides comprising the CD8 antigen binding molecules for selectively modulating the function of CD8+ T cells over other immune cells. In addition, the present disclosure also provides polynucleotides encoding the disclosed antigen binding molecules and fusion polypeptides, and vectors and host cells comprising such polynucleotides. The present disclosure further provides methods for producing the antigen binding molecules and fusion polypeptides, pharmaceutical compositions comprising the same, and uses thereof.
    Type: Application
    Filed: October 22, 2021
    Publication date: May 26, 2022
    Inventors: Yik Andy YEUNG, Ivana DJURETIC, Paul BESSETTE, Wei CHEN, Sherman Michael CHIN, Kelly Dare MOYNIHAN, Henry C. NGUYEN, Irene NI, Danielle C. PAPPAS, Terrence PARK